Zai Lab market cap ZLAB
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $2.7B
- Highest close in our data
- $16.9B
- May 2021
Zai Lab is worth $2.7B at the close on Oct 23, 2026, at $24.03 a share.
That is down 7% over the last year and down 73% over five years.
Its highest close in our data was $16.9B in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.7B | $1.8B | $2.9B | +33% |
| 2025 | $2B | $2B | $4.4B | −24% |
| 2024 | $2.7B | $1.4B | $3.2B | −2% |
| 2023 | $2.7B | $2.2B | $4.7B | −10% |
| 2022 | $3B | $2.3B | $5.7B | −50% |
| 2021 | $6.1B | $6.1B | $16.9B | −35% |
| 2020 | $9.3B | $2.3B | $9.3B | +294% |
| 2019 | $2.3B | $1.1B | $2.5B | +105% |
| 2018 | $1.1B | $793.7M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Zai Lab's size, closest first, today.
| Company | Market cap |
|---|---|
| ZLABZai Lab | $2.7B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| Peer median | $2.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Zai Lab
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.